XML 37 R17.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Income Taxes
12 Months Ended
Dec. 31, 2019
Income Tax Disclosure [Abstract]  
Income Taxes Income Taxes

Income tax expense for income taxes is as follows (in thousands):
 
Year Ended
December 31, 2019
 
Transition Period Ended
December 31, 2018
 
Fiscal Year Ended June 30,
 
 
 
2018
 
2017
Federal
 
 
 
 
    
 
    
Current
$

 
$

 
$

 
$

Deferred

 

 

 

Total Federal

 

 

 

State
 
 
 
 
 
 
 
Current

 

 
2

 
1

Deferred

 

 

 

Total State

 

 
2

 
1

Foreign
 
 
 
 
 
 
 
Current

 

 
154

 
19

Deferred

 

 

 

Total Foreign

 

 
154

 
19

Total income tax expense
$

 
$

 
$
156

 
$
20



A reconciliation of the statutory tax rates and the effective tax rates for the year ended December 31, 2019, the transition period ended December 31, 2018 and fiscal years ended June 30, 2018 and 2017 is as follows:
 
Year Ended
December 31, 2019
 
Transition Period Ended
December 31, 2018
 
Fiscal Year Ended June 30,
 
 
 
2018
 
2017
Statutory rate
(21.0
)%
 
(21.0
)%
 
(28.0
)%
 
(34.0
)%
Foreign income tax
 %
 
 %
 
 %
 
 %
Change in valuation allowance
29.9
 %
 
34.4
 %
 
21.1
 %
 
21.9
 %
State income taxes, (net of federal tax benefit)
(7.5
)%
 
(8.8
)%
 
(4.3
)%
 
(4.8
)%
Permanent differences, (primarily warrant-related expenses)
(1.4
)%
 
(4.2
)%
 
11.3
 %
 
15.3
 %
Other
 %
 
(0.4
)%
 
 %
 
1.6
 %
Effective rate
 %
 
 %
 
0.1
 %
 
 %


The tax effects of temporary differences that give rise to significant portions of the Company’s deferred tax assets and liabilities as of December 31, (in thousands):
 
2019
 
2018
Deferred tax assets:
 
 
 
NOL carryforwards
$
203,928

 
$
132,841

Research and development credits
28,535

 
23,118

Liability related to sale of future royalties
49,228

 
49,217

Deferred revenue
18,286

 

Disallowed interest expense
13,474

 

Other
5,807

 
3,088

Total
319,258

 
208,264

Valuation allowance
(317,828
)
 
(206,397
)
Net deferred assets
$
1,430

 
$
1,867

Deferred tax liabilities:
 
 
 
Property and equipment
$
(1,430
)
 
$
(1,867
)
Net deferred assets and liabilities
$

 
$

A valuation allowance is provided when it is more likely than not that some portion or all of the deferred tax assets will not be realized. The valuation allowances for the year ended December 31, 2019, and the Transition Period ended December 31, 2018 have been applied to offset the deferred tax assets in recognition of the uncertainty that such tax benefits will be realized as the Company continues to incur losses. The differences between book income and tax income primarily relate to the temporary differences from depreciation and stock compensation expenses, and deferred book income that is realized for tax.

At December 31, 2019, and the Transition Period ended December 31, 2018, the Company has available net operating loss carry forwards for federal income tax reporting purposes of approximately $769.1 million and $516.6 million for state income tax reporting purposes of approximately $593.6 million and $343.0 million, respectively, which expire at various dates between 2020 and 2038. For tax years 2018 onward, Federal net operating losses have an indefinite life but are limited to annual utilization by 80% taxable income.

The Company accounts for uncertain tax benefits in accordance with the provisions of section 740-10 of the Accounting for Uncertainty in Income Taxes Topic of the FASB ASC. Of the total unrecognized tax benefits at December 31, 2019 and 2018, approximately $2.5 million was recorded in both years as a reduction to deferred tax assets, which caused a corresponding reduction in the Company’s valuation allowance of $2.5 million in both years. The Company does not anticipate that the amount of unrecognized tax benefits as of December 31, 2019 will change materially within the 12-month period following December 31, 2019. The change in unrecognized tax benefits are presented below (in thousands):
 
Year Ended
December 31, 2019
 
Transition Period Ended
December 31, 2018
 
 
Change in unrecognized tax benefits
 
 
 
Balance at beginning of year
$
2,521

 
$

Gross increases related to current period tax positions

 

Gross increases related to prior periods tax positions

 
2,521

Gross decreases in tax positions

 

Expiration of the statute of limitations

 

Balance at end of year
$
2,521

 
$
2,521



The Company will recognize potential interest and penalties related to income tax positions as a component of the provision for income taxes on the Consolidated Statements of Comprehensive Loss in any future periods in which the Company must record a liability. The Company is subject to examination for United States Federal and Foreign tax purposes for 2013 and forward and for New Jersey 2015 and forward. The Company conducts business and files tax returns in New Jersey.

For fiscal year 2016, the Company sold certain State of New Jersey State Net Operating Losses (“NOL”) and Research and Development (“R&D”) tax credits through the New Jersey Economic Development Authority Technology Business Tax Certificate Transfer Program. Pursuant to such sale, for the year ended June 30, 2016, the Company recorded a tax benefit of $5.1 million, as a result of its sale of approximately $66.2 million, of New Jersey State NOL and $1.5 million of New Jersey R&D tax credits. There were no sales of NOL or R&D for the year ended December 31, 2019, the Transition Period or 2018 or 2017 fiscal years.

The Global Intangible Low-tax Income ("GILTI") provisions of the 2017 Tax Act require the Company to include in its United States income tax return foreign subsidiary earnings in excess of an allowable return on the foreign subsidiary’s tangible assets. The Company expects that it may be subject to incremental United States tax on GILTI income in the future but not for the for the year ended December 31, 2019. The Company has elected to account for GILTI tax in the period in which it is incurred, and therefore has not provided any deferred tax impacts of GILTI in its consolidated financial statements.
As a result of U.S. tax reform legislation, distributions of profits from non-U.S. subsidiaries are not expected to cause a significant incremental U.S. tax impact in the future. However, distributions may be subject to non-U.S. withholding taxes if profits are distributed from certain jurisdictions. U.S. federal income taxes have not been provided on undistributed earnings of our international subsidiaries as it is our intention to reinvest any earnings into the respective subsidiaries. It is not practicable to estimate the amount of tax that might be payable if some or all of such earnings were to be repatriated due to the legal structure and complexity of U.S. and local tax laws. As of December 31, 2019, and 2018, there are no undistributed earnings.

As a result of the reduction in the U.S. corporate income tax rate, the Company revalued its ending net deferred tax assets as of June 30, 2018, which resulted in a provisional expense of $59.5 million which was offset by an associated change in valuation allowance. In the second quarter of the Transition Period, the Company completed its analysis to determine the effect of the Tax Act and recorded no further adjustments.